Table of Contents
May 1, 2020; Volume 61,Issue 5
Mavriopoulou, Eleni
- You have accessResponse Prediction of 177Lu-PSMA-617 Radioligand Therapy Using Prostate-Specific Antigen, Chromogranin A, and Lactate DehydrogenaseHendrik Rathke, Tim Holland-Letz, Walter Mier, Paul Flechsig, Eleni Mavriopoulou, Manuel Röhrich, Klaus Kopka, Markus Hohenfellner, Frederik Lars Giesel, Uwe Haberkorn and Clemens KratochwilJournal of Nuclear Medicine May 1, 2020, 61 (5) 689-695; DOI: https://doi.org/10.2967/jnumed.119.231431
Mcdonald, Elizabeth S.
- You have accessBreast Cancer 18F-ISO-1 Uptake as a Marker of Proliferation StatusElizabeth S. McDonald, Robert K. Doot, Anthony J. Young, Erin K. Schubert, Julia Tchou, Daniel A. Pryma, Michael D. Farwell, Anupma Nayak, Amy Ziober, Michael D. Feldman, Angela DeMichele, Amy S. Clark, Payal D. Shah, Hsiaoju Lee, Sean D. Carlin, Robert H. Mach and David A. MankoffJournal of Nuclear Medicine May 1, 2020, 61 (5) 665-670; DOI: https://doi.org/10.2967/jnumed.119.232363
Meyer, Philipp T.
- Open AccessNuclear Medicine Operations in the Times of COVID-19: Strategies, Precautions, and ExperiencesJohannes Czernin, Stefano Fanti, Philipp T. Meyer, Martin Allen-Auerbach, Marcus Hacker, Mike Sathekge, Rodney Hicks, Andrew M. Scott, Jun Hatazawa, Mijin Yun, Heiko Schöder, Peter Bartenstein and Ken HerrmannJournal of Nuclear Medicine May 1, 2020, 61 (5) 626-629; DOI: https://doi.org/10.2967/jnumed.120.245738
Mier, Walter
- You have accessResponse Prediction of 177Lu-PSMA-617 Radioligand Therapy Using Prostate-Specific Antigen, Chromogranin A, and Lactate DehydrogenaseHendrik Rathke, Tim Holland-Letz, Walter Mier, Paul Flechsig, Eleni Mavriopoulou, Manuel Röhrich, Klaus Kopka, Markus Hohenfellner, Frederik Lars Giesel, Uwe Haberkorn and Clemens KratochwilJournal of Nuclear Medicine May 1, 2020, 61 (5) 689-695; DOI: https://doi.org/10.2967/jnumed.119.231431
Moadel, Renée M.
- Open AccessDiagnostic Evaluation of Pulmonary Embolism During the COVID-19 PandemicLionel S. Zuckier, Renée M. Moadel, Linda B. Haramati and Leonard M. FreemanJournal of Nuclear Medicine May 1, 2020, 61 (5) 630-631; DOI: https://doi.org/10.2967/jnumed.120.245571
Mokrane, Fatima-Zohra
- You have accessEarly 18F-FDG PET/CT Response Predicts Survival in Relapsed or Refractory Hodgkin Lymphoma Treated with NivolumabAiping Chen, Fatima-Zohra Mokrane, Lawrence H. Schwartz, Franck Morschhauser, Apasia Stamatoullas, Jean-Marc Schiano de Colella, Laetitia Vercellino, Olivier Casasnovas, Adrien Chauchet, Alain Delmer, Emmanuelle Nicolas-Virelizier, Hervé Ghesquières, Marie-Pierre Moles-Moreau, Anna Schmitt, Rémy Dulery, Krimo Bouabdallah, Cecile Borel, Mohamed Touati, Benedicte Deau-Fischer, Frédéric Peyrade, Romain-David Seban, Guillaume Manson, Philippe Armand, Roch Houot and Laurent DercleJournal of Nuclear Medicine May 1, 2020, 61 (5) 649-654; DOI: https://doi.org/10.2967/jnumed.119.232827
Moles-moreau, Marie-Pierre
- You have accessEarly 18F-FDG PET/CT Response Predicts Survival in Relapsed or Refractory Hodgkin Lymphoma Treated with NivolumabAiping Chen, Fatima-Zohra Mokrane, Lawrence H. Schwartz, Franck Morschhauser, Apasia Stamatoullas, Jean-Marc Schiano de Colella, Laetitia Vercellino, Olivier Casasnovas, Adrien Chauchet, Alain Delmer, Emmanuelle Nicolas-Virelizier, Hervé Ghesquières, Marie-Pierre Moles-Moreau, Anna Schmitt, Rémy Dulery, Krimo Bouabdallah, Cecile Borel, Mohamed Touati, Benedicte Deau-Fischer, Frédéric Peyrade, Romain-David Seban, Guillaume Manson, Philippe Armand, Roch Houot and Laurent DercleJournal of Nuclear Medicine May 1, 2020, 61 (5) 649-654; DOI: https://doi.org/10.2967/jnumed.119.232827
Morgenstern, Alfred
- You have accessPatients Resistant Against PSMA-Targeting α-Radiation Therapy Often Harbor Mutations in DNA Damage-Repair–Associated GenesClemens Kratochwil, Frederik L. Giesel, Claus-Peter Heussel, Daniel Kazdal, Volker Endris, Cathleen Nientiedt, Frank Bruchertseifer, Maximilian Kippenberger, Hendrik Rathke, Jonas Leichsenring, Markus Hohenfellner, Alfred Morgenstern, Uwe Haberkorn, Stefan Duensing and Albrecht StenzingerJournal of Nuclear Medicine May 1, 2020, 61 (5) 683-688; DOI: https://doi.org/10.2967/jnumed.119.234559
Morschhauser, Franck
- You have accessEarly 18F-FDG PET/CT Response Predicts Survival in Relapsed or Refractory Hodgkin Lymphoma Treated with NivolumabAiping Chen, Fatima-Zohra Mokrane, Lawrence H. Schwartz, Franck Morschhauser, Apasia Stamatoullas, Jean-Marc Schiano de Colella, Laetitia Vercellino, Olivier Casasnovas, Adrien Chauchet, Alain Delmer, Emmanuelle Nicolas-Virelizier, Hervé Ghesquières, Marie-Pierre Moles-Moreau, Anna Schmitt, Rémy Dulery, Krimo Bouabdallah, Cecile Borel, Mohamed Touati, Benedicte Deau-Fischer, Frédéric Peyrade, Romain-David Seban, Guillaume Manson, Philippe Armand, Roch Houot and Laurent DercleJournal of Nuclear Medicine May 1, 2020, 61 (5) 649-654; DOI: https://doi.org/10.2967/jnumed.119.232827
Mosley, Michael
- Open AccessImaging DNA Damage Repair In Vivo After 177Lu-DOTATATE TherapyEdward O’Neill, Veerle Kersemans, P. Danny Allen, Samantha Y.A. Terry, Julia Baguña Torres, Michael Mosley, Sean Smart, Boon Quan Lee, Nadia Falzone, Katherine A. Vallis, Mark W. Konijnenberg, Marion de Jong, Julie Nonnekens and Bart CornelissenJournal of Nuclear Medicine May 1, 2020, 61 (5) 743-750; DOI: https://doi.org/10.2967/jnumed.119.232934